Tag: drug design

Cellestia Biotech is initiating a new drug discovery program focused on TFs. The programme, which addresses unmet medical needs in cancer, autoimmune and inflammatory disorders (AIIDs), is launched in collaboration with Vincent Zoete

The PrecisionMed.ch website, developed by the SIB Swiss Institute of Bioinformatics, in collaboration with the University of Lausanne and the CHUV (Lausanne University Hospital), with the support of the SantéPerSo initiative, offers illustrated...

In 2019, the SIB Bioinformatics Awards will be presented for the 10th time, providing a great occasion to reach out to past laureates and ask them where they are now in their career. In this interview, we met with Shameer Khader, recipient of...

On 16 December 2018, the count of total jobs run on the SIB Resource SwissDrugDesign passed the symbolic one-million mark.

Integrating biological and chemical knowledge for a more complete understanding of biological systems – and better links between SIB and ELIXIR Core Data Resources.

Take a closer look at an SIB Resource dedicated to making protein modelling accessible to life scientists from around the world: on the occasion of its 25th anniversary, we put a few questions to the SWISS-MODEL development team...

Bioinformatics is fundamental to precision medicine. But why? How do hospitals and researchers benefit from bioinformatics to help patients? Canal9 TV Channel, the Oncology department of UNIL/CHUV and SIB all set out together to find answers to...

What we do The overall objective of our research is to understand the role that structure and dynamics play in the definition of the function of biomolecules. In order to perform their function, proteins and other biological molecules undergo a...

What we do The laboratory specializes in the development of computer-aided algorithms, programs and databases for protein engineering, drug design and structure-based immunoinformatics with applications in oncology, notably in immunotherapy of...

What we do In the Computational Structural Biology (CSB) Group, we focus on the development of methods and algorithms to model, simulate and analyse three-dimensional protein structures and their molecular properties in order to apply these...

What we do The Molecular Modelling Group studies molecular interactions using modelling techniques such as homology modelling, molecular dynamics, docking and free energy simulations. Our main activity consists in developing and applying methods...

What we do The Molecular Modelling Group studies molecular interactions using modelling techniques such as homology modelling, molecular dynamics, docking and free energy simulations. Our main activity consists in developing and applying methods...

Discover the story of the patients for whom personalized medicine is already a reality. A TV documentary invites you to follow them with a team of oncologists, pathologists, biologists and bioinformaticians, in their search for a treatment against...

Hacking a cell’s communication system is a common feat of information diseases, such as cancer. Understanding how information is conveyed at the molecular level is therefore crucial. So far, one of the most common cell receptors was thought to...

Over 650 people, including school classes, took part in our outreach activities around bioinformatics on the occasion of the University of Lausanne Open House (Mystères de l’UNIL) and the Night of the Museums in Geneva, on 18-21 May. The two events...

Science images exhibition, café scientifique, night of the museums, open house at the University of Lausanne, hackathon...

Bringing medicinal chemistry and bioinformatics to the layman, by using a didactic online platform based on professional tools, is the goal of the Drug Design Workshop. Developed in 2015 by SIB researchers, together with training and outreach...

Today in the national news, Marie-Claude Blatter (Responsible - SIB Outreach activities) and Vincent Zoete (Associate director - Molecular Modelling group) presented SIB's role in drug design and bioinformatics outreach on the Radio Télévision...

First, a definition Life scientists and clinicians have long tried to assemble data and evidence to find the right answers to fundamental questions. Today, however, there is no shortage of data, and we find ourselves with a different issue. New...

Identifying and supporting SIB Resources Every four years, the Institute’s External Scientific Advisory Board (SAB) provides recommendations on the portfolio of SIB-supported Resources. By taking into account competitive criteria – such as the...